Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
- PMID: 1312985
- DOI: 10.1002/hep.1840150417
Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
Abstract
Two hundred twelve Italian patients with genetic hemochromatosis (181 men, mean age 50 +/- 11 yr; and 31 women, mean age 49 +/- 10 yr) were followed for a median period of 44 mo (range = 3 to 218 mo). Alcohol abuse was present in 31 subjects (15%), and chronic HBV and HCV infection were seen in 19 (9%) and 35 (24%) of 145 cases tested, respectively. Twenty-four patients (11%) had concomitant beta-thalassemia trait. Liver biopsy revealed cirrhosis in 146 and a noncirrhotic pattern in the other 66. Perls' stain was degree III in 37 patients and IV in 171 patients. One hundred eighty-five patients underwent weekly venesection, and iron depletion was achieved in 122 cases after total iron removal of 3 to 41 gm. Death occurred in 44 patients after 3 to 198 mo and was due to hepatocellular carcinoma in 20 cases, liver failure in 10, extrahepatic cancer in six, heart failure in three and hemochromatosis unrelated causes in five. Cancer has developed in seven other patients still alive (hepatocellular in five and extrahepatic in two). No deaths were observed among noncirrhotic patients; cumulative survival rates in cirrhotic patients were 85%, 75%, 60% and 47% at 3, 5, 8 and 10 yr, respectively. Univariate analysis in the 146 cirrhotic patients showed that age greater than 60 yr, alcohol abuse, cardiomyopathy, skin pigmentation, portal hypertension, hypoalbuminemia, hypergammaglobulinemia and Child class B or C had significant negative prognostic value. At multivariate analysis, only alcohol abuse, gamma-globulins greater than 2.0 gm/dl and Child class B or C maintained their negative prognostic values (p less than 0.01, hazard ratio 2.7; p less than 0.001, hazard ratio 2.8; and p less than 0.001, hazard ratio 4.3, respectively).
Similar articles
-
Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.N Engl J Med. 1985 Nov 14;313(20):1256-62. doi: 10.1056/NEJM198511143132004. N Engl J Med. 1985. PMID: 4058506
-
Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis.Hepatology. 1994 Dec;20(6):1426-31. doi: 10.1002/hep.1840200608. Hepatology. 1994. PMID: 7982640
-
Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis.Can J Gastroenterol. 2006 Apr;20(4):257-60. doi: 10.1155/2006/428048. Can J Gastroenterol. 2006. PMID: 16609753 Free PMC article.
-
[Idiopathic hemochromatosis].Minerva Med. 1985 Mar 31;76(13):627-34. Minerva Med. 1985. PMID: 2986052 Review. Italian.
-
Hemochromatosis: course and treatment.Annu Rev Med. 1976;27:143-9. doi: 10.1146/annurev.me.27.020176.001043. Annu Rev Med. 1976. PMID: 180870 Review. No abstract available.
Cited by
-
Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.Am J Pathol. 2010 Feb;176(2):1006-17. doi: 10.2353/ajpath.2010.090249. Epub 2009 Dec 17. Am J Pathol. 2010. PMID: 20019189 Free PMC article.
-
Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis.Gut. 2003 Aug;52(8):1178-81. doi: 10.1136/gut.52.8.1178. Gut. 2003. PMID: 12865278 Free PMC article.
-
Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women.J Diabetes Complications. 2014 Mar-Apr;28(2):177-84. doi: 10.1016/j.jdiacomp.2013.11.007. Epub 2013 Nov 26. J Diabetes Complications. 2014. PMID: 24360972 Free PMC article.
-
Uncoupled iron homeostasis in type 2 diabetes mellitus.J Mol Med (Berl). 2017 Dec;95(12):1387-1398. doi: 10.1007/s00109-017-1596-3. Epub 2017 Oct 3. J Mol Med (Berl). 2017. PMID: 28971221
-
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment.Cancer Med. 2019 Mar;8(3):1054-1065. doi: 10.1002/cam4.1998. Epub 2019 Feb 21. Cancer Med. 2019. PMID: 30791221 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical